Clinical Trials · NCT02127437
Lanreotide In Polycystic Kidney Disease Study
- Phase
- Phase 3
- Recruitment status
- Completed
- Sponsor
- Assistance Publique - Hôpitaux de Paris
- Enrollment
- 159
- Start date
- Sep 2014
- Locations
- 1 site, France
- Primary endpoint
- Glomerular filtration rate (GFR)